Daniel J. Abrams, M.D., CEO
Dr. Abrams is a cofounder of Cerebral Therapeutics and serves as its startup CEO. Prior to founding Cerebral Therapeutics, Dr. Abrams founded Sierra Neuropharmaceuticals, Inc., raising $21.5 million in Series A venture capital and put together a world class team of advisers, physician leaders and executives to form its board of directors. Dr. Abrams was active with Sierra Neuropharmaceuticals, Inc. until July of 2009. Dr. Abrams practiced as a neurosurgeon and served as head of the Department of Neurosurgery at St. Joseph’s Hospital in Denver. Dr. Abrams’ practical experience with implantable pumps and medications in neurology and psychiatry, and his experience with interdisciplinary medical teams and research groups, make him uniquely qualified to lead Cerebral Therapeutics in its focus of clinically testing brain drug delivery.
Ashwini Sharan, M.D., Senior Medical and Scientific Advisor
Dr. Sharan is the Surgical Director of the Epilepsy Center and the Residency Program Director as a Professor of Neurological Surgery and Neurology at Jefferson University. In addition, Dr. Sharan is the incoming President of the North American Neuromodulation Society and is on the Board of Directors of the Congress of Neurological Surgeons. Dr. Sharan is author of numerous papers, holds multiple patents and serves as an international physician leader in understanding neurological illness, new therapy development, education, and patient advocacy.
David Jenkins, Board Member
David Jenkins has spent more than 30 years as a business entrepreneur. He has had much success starting companies and developing them into market leaders.